Decoding aberrant glycosylation in colorectal cancer: From Glycosyaltion characterization, expression regulation to potential clinical applications
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026
DOI: 10.1016/j.bbcan.2025.189513 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Zihan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Colorectal cancer (CRC) exhibits extensive alterations in glycosylation, characterized by remodeling of glycan chain structures, aberrant terminal modifications, and dysregulated glycosyltransferase activity. These alterations are intimately associated with malignant phenotypes, such as tumor invasion, migration and proliferation, and contribute to shaping an immunosuppressive tumor microenvironment (TME). In this review, we first delineate major glycosylation types implicated in CRC, including O-GalNAc glycosylation, O-GlcNAcylation, N-glycosylation, sialylation, glycosphingolipid, glycosaminoglycan, and other special antigens, and summarize the key enzymatic machinery governing their biosynthesis. We further explore how glycosylation reprogramming drives oncogenic signaling and cellular plasticity. Importantly, we highlight recent advances in CRC-specific glycosylation-based diagnostic, prognostic, and therapeutic strategies. By summarizing current mechanistic and translational insights, this review aims to establish a conceptual framework for elucidating CRC-specific glycosylation alterations and evaluating their clinical translational potential, with the goal of improving early diagnosis, prognostic assessment, and targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
- Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: liujian2004811@mail.ccmu.edu.cn.
- Medical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: wentao@mail.ccmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, Z., Dong, X., Liu, J., & Wen, T. (2026). Decoding aberrant glycosylation in colorectal cancer: From Glycosyaltion characterization, expression regulation to potential clinical applications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189513
Vancouver
Li Z, Dong X, Liu J, Wen T. Decoding aberrant glycosylation in colorectal cancer: From Glycosyaltion characterization, expression regulation to potential clinical applications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2025.189513
BibTeX
@article{Li2026,
author = {Li, Zihan and Dong, Xichen and Liu, Jian and Wen, Tao},
title = {Decoding aberrant glycosylation in colorectal cancer: From Glycosyaltion characterization, expression regulation to potential clinical applications},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
doi = {10.1016/j.bbcan.2025.189513}
}
EUVIMED